Close
ACHEMA MIDDLE EAST 2026

Huge Investment In Indiana For Tirzepatide API Production

It is well to be noted that a fresh $5.3 billion investment for pharma giant Eli Lilly and Company’s manufacturing site based in Lebanon,...

Germany – A Strong Force For Pharmaceutical Drug Reshoring

As part of its endeavors to throttle the pharma sector domestically, the German government has gone ahead with the adoption of a strategy paper...

Pharma Solvents Industry Eyeing A $6bn Valuation By 2033

The pharmaceutical solvents sector has gone on to secure a valuation worth $3.9 billion in 2023 and is all set to scale the $6...

Deep Dive Into The Pharmaceutical Fine Chemicals Market

The pharmaceutical fine chemicals market is all set to showcase significant growth, with an increase from $136 billion in 2024 to an expected $233...

Study Suggests Consistent Rise In Pharma Chemicals Market

It is worth noting that the pharmaceutical chemicals market happens to be segmented by Type which includes Reagents, Catalysts, Solvents, KSMs and intermediates, Building...

Key Trends In European Active Pharma Ingredients Market

As per one of the recently held studies in 2024, the Europe Active Pharmaceutical Ingredients- API market size happened to be anticipated at $45.43...

Europe API Market To Reach $80bn By 2033 – Study Predicts

The active pharma ingredient market in Europe has been a matter of much discussion, and no wonder it has laid a very exclusive but...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...